AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain

被引：46

作者：

Hosohata, K

Quock, RM

Hosohata, Y

Burkey, TH

Makriyannis, A

Consroe, P

Roeske, WR

Yamamura, HI

机构：

[1] UNIV ARIZONA, HLTH SCI CTR, COLL MED, DEPT PHARMACOL, TUCSON, AZ 85724 USA

[2] UNIV ARIZONA, HLTH SCI CTR, DEPT PHARMACOL & TOXICOL, TUCSON, AZ 85724 USA

[3] UNIV ARIZONA, HLTH SCI CTR, DEPT BIOCHEM, TUCSON, AZ 85724 USA

[4] UNIV ARIZONA, HLTH SCI CTR, DEPT PSYCHIAT, TUCSON, AZ 85724 USA

[5] UNIV ARIZONA, HLTH SCI CTR, PROGRAM NEUROSCI, TUCSON, AZ 85724 USA

[6] UNIV CONNECTICUT, SCH PHARM, STORRS, CT 06269 USA

[7] UNIV ILLINOIS, COLL MED, DEPT BIOMED SCI, ROCKFORD, IL 61107 USA

来源：

LIFE SCIENCES | 1997年 / 61卷 / 09期

关键词：

cannabinoid antagonist; S-35]GTP gamma S binding; guinea pig;

D O I：

10.1016/S0024-3205(97)00596-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

AM630 has been demonstrated to be a cannabinoid receptor antagonist in the mouse brain and vas deferens. Conversely, it was recently reported that AM630 acts as a cannabinoid agonist in the guinea pig ileum. This research was designed to determine whether the difference in the action of AM630 is species specific. Studies conducted in guinea pig brain reveal that AM630 antagonizes the stimulatory effect of the cannabinoid agonist WIN 55,212-2 on [S-35]GTP gamma S binding suggesting that difference in AM630 activity in different tissues is not due to species (C) 1997 Elsevier Science Inc.

引用

页码：PL115 / PL118

页数：4

共 50 条

[31] Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo
Marleau, S
GriffithsJohnson, DA
Collins, PD
Bakhle, YS
Williams, TJ
Jose, PJ
JOURNAL OF IMMUNOLOGY, 1996, 157 (09): : 4141 - 4146
[32] Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry
Zhang, Q
Ma, P
Wang, WQ
Cole, RB
Wang, GD
JOURNAL OF MASS SPECTROMETRY, 2004, 39 (06): : 672 - 681
[33] Effects of the cannabinoid receptor antagonist, AM251, on the cardiovascular responses to the cannabinoid receptor agonist, WIN 55212-2, and to anandamide, in conscious rats
Gardiner, SM
March, JE
Kemp, PA
Bennett, T
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
[34] THE ANGIOTENSIN-IV RECEPTOR IN GUINEA-PIG BRAIN
MILLERWING, AV
HANESWORTH, JM
SWANSON, GN
COOK, VI
STOBB, JW
HALL, KL
WRIGHT, JW
HARDING, JW
FASEB JOURNAL, 1992, 6 (04): : A1576 - A1576
[35] Cannabinoid CB1 receptor in the guinea-pig: Partial sequencing and identification of an atrial presynaptic receptor
Kurz, C. M.
Kathmann, M.
Schlicker, E.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 25 - 25
[36] The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis
Matsuda, K
Mikami, Y
Takeda, K
Fukuyama, S
Egawa, S
Sunamura, M
Maruyama, I
Matsuno, S
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 207 (02): : 99 - 107
[37] Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum
LopezRedondo, F
Lees, GM
Pertwee, RG
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) : 330 - 334
[38] Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
Coutts, AA
Irving, AJ
Mackie, K
Pertwee, RG
Anavi-Goffer, S
JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 448 (04) : 410 - 422
[39] Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
Coutts, AA
Pertwee, RG
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) : 1557 - 1566
[40] The effects of cannabinoid CBI receptor antagonist AM 251 on locomotor/exploratory behaviour and body weight in mice
Slais, K
Landa, L
Sulcova, A
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S417 - S417

← 1 2 3 4 5 →